Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Dicyclohexylcarbodiimide interaction with sarcoplasmic reticulum: inhibition of Ca/sup 2 +/ efflux

Journal Article · · J. Biol. Chem.; (United States)
OSTI ID:6771679
Dicyclohexylcarbodiimide (DCCD), a hydrophobic carboxyl reagent, inhibited Ca/sup 2 +/ release from Ca/sup 2 +/-loaded sarcoplasmic reticulum vesicles, induced by elevated pH, tetraphenylboron, ATP + P/sub i/, or membrane modification with acetic anhydride. Under the conditions used, the same concentrations of DCCD were required for inhibition of Ca/sup 2 +/ release, Ca/sup 2 +/-ATPase activity, and Ca/sup 2 +/ uptake. On the other hand, free Ca/sup 2 +/ or alkaline pH prevented the inhibition by DCCD of Ca/sup 2 +/-ATPase and coupled Ca/sup 2 +/ transport but not that of Ca/sup 2 +/ release. Moreover, several hydrophilic carboxyl reagents inhibited Ca/sup 2 +/-APTase but not Ca/sup 2 +/ release. The authors suggest that a carboxyl residue(s), located in a hydrophobic region of a protein(s), is involved in the control of Ca/sup 2 +/ release, where DCCD interaction with this group blocks Ca/sup 2 +/ release. This group is distinct from the one involved in the inhibition of Ca/sup 2 +/-ATPase. DCCD also inhibited (/sup 3/H)ryanodine binding to junctional sarcoplasmic reticulum membranes. The presence of Ca/sup 2 +/ or an alkaline pH only slightly affects the degree of inhibition of ryanodine binding by DCCD. Incubation of the membranes with (/sup 14/C)DCCD resulted in labeling of 350-, 170-, 140-, 53-, and 30-kDa proteins in addition to the Ca/sup 2 +/-ATPase. The involvement of one or all of the DCCD-labeled proteins in Ca/sup 2 +/ release and ryanodine binding is discussed.
Research Organization:
Ben Gurion Univ. of the Negev, Beer Sheva (Israel)
OSTI ID:
6771679
Journal Information:
J. Biol. Chem.; (United States), Journal Name: J. Biol. Chem.; (United States) Vol. 263:13; ISSN JBCHA
Country of Publication:
United States
Language:
English